Home/Dependencies/Products/Insulin Pumps & CGM Sensors

Insulin Pumps & CGM Sensors

Critical dependencyPosition-earlyMedical DevicesReasoned estimateHS 9018.90
$0.18 bnAnnual import
5%Indian capability
4,850Supplier concentration (HHI)
₹1,000 crTo localise

Why India imports it. Medtronic, Dexcom, Abbott dominate; Indian startups (Pulse Active, BeatO) only on B2C.

Why it matters. India has 100M+ diabetics; device access drives outcomes.

Can India localise it? Partial - 5-7 years for sensor chemistry.

Where it comes from. USA (65%), Germany (20%), Switzerland (15%).

Scorecard

The ten indices

CMDI 69.25Dependency
LPI 41.25Localisation potential
IAI 59.75Investment attractiveness
SRI 69.25Supply risk
SCI 58.25Supply-chain complexity
TRI 41Technology readiness
IMI 67Industrial multiplier
NSRI 58.25National-security relevance
EPI 59.5Export potential
ICGI 71.75Capability gap
Who makes it

Manufacturers

In India

Pulse Active Detection NetworkBeatO

Global leaders

MedtronicDexcomAbbott

Intelligence

Related signals

Sources

Primary references

Confidence: Reasoned estimate. Reasoned estimate. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).